Christopher Flowers, MD, MS
Articles
Polatuzumab Vedotin Regimen Yields ‘Meaningful’ Benefit in DLBCL, Expert Says
April 19th 2023Polatuzumab vedotin-piiq plus R-CHP can reduce the need for any subsequent lines of therapy for patients with diffuse large B-cell lymphoma, according to an expert from The University of Texas MD Anderson Cancer Center.
The Role of the Comprehensive Geriatric Assessment in the Evaluation of the Older Cancer Patient
Carmelo Blanquicett, MD, PhD, FACP;Theodore Johnson, II, MD, MPH;Christopher Flowers, MD, MS;Jonathon B. Cohen, MD, MS
November 14th 2019Geriatric assessments have now been recommended as part of the standard evaluation of an older adult considering cancer therapy.
Latest Updated Articles
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Published: November 7th 2024 | Updated: November 21st 2024
Implementing a Multidisciplinary Lifestyle Medicine Clinic for Cancer Survivorship
Published: November 7th 2024 | Updated: November 21st 2024
Initial Workup for a Newly Diagnosed Pancreatic Cancer Patient
Published: November 7th 2024 | Updated: November 21st 2024
Treatment Considerations for Disease Progression
